Semaglutide Use Linked to Erythromelalgia Remission

• by Kathryn Wighton

• April 22, 2026

Overview of Findings: Real-World Outcomes of Systemic Therapies for Moderate-to-Severe Atopic Dermatitis in Children Aged 12 and Younger from the PEDISTAD Registry

• by Amy S. Paller, Danielle Marcoux, Michele Ramien, Eulalia Baselga, Vania Oliveira de Carvalho, Ledit R. F. Ardusso, Marlies de Graaf, Suzanne Pasmans, Mirna Toledo-Bahena, Cory J. Rubin, Joel C. Joyce, Lara Wine Lee, Rajan Gupta, Bryan Adams, Marius Ardeleanu, Annie Zhang

• April 17, 2026

FDA approves first therapy for symptomatic dermographism

The oral BTK inhibitor produced a complete hive response in 29.3% of treated patients at week 12.

• by Teraya Smith

• October 7, 2026

• 2 min

A Systematic Review of Electrochemotherapy Applications in Pediatric Patients

• by M. A. Formstone, J. J. Neville, A. N. Smith, A. C. Sedgwick, I. Diez-Perez, P. A. Patel, J. Anderson, S. Giuliani

• April 22, 2026